|
1
|
GBD 2017 Pancreatic Cancer Collaborators.
The global, regional, and national burden of pancreatic cancer and
its attributable risk factors in 195 countries and territories,
1990-2017: A systematic analysis for the global burden of disease
study 2017. Lancet Gastroenterol Hepatol. 4:934–947.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hu JX, Zhao CF, Chen WB, Liu QC, Li QW,
Lin YY and Gao F: Pancreatic cancer: A review of epidemiology,
trend, and risk factors. World J Gastroenterol. 27:4298–4321.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Klein AP: Pancreatic cancer epidemiology:
Understanding the role of lifestyle and inherited risk factors. Nat
Rev Gastroenterol Hepatol. 18:493–502. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
McGuigan A, Kelly P, Turkington RC, Jones
C, Coleman HG and McCain RS: Pancreatic cancer: A review of
clinical diagnosis, epidemiology, treatment and outcomes. World J
Gastroenterol. 24:4846–4861. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wang Z and Tian YP: Clinical value of
serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of
pancreatic carcinoma. Mol Clin Oncol. 2:265–268. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kato Y, Yamada S, Suenaga M, Takami H,
Niwa Y, Hayashi M, Iwata N, Kanda M, Tanaka C, Nakayama G, et al:
Impact of the controlling nutritional status score on the prognosis
after curative resection of pancreatic ductal adenocarcinoma.
Pancreas. 47:823–829. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sakamoto T, Kishino M, Murakami Y,
Miyatani K, Hanaki T, Shishido Y, Kihara K, Matsunaga T, Yamamoto
M, Tokuyasu N and Fujiwara Y: The cachexia index is a prognostic
factor for patients with recurrent pancreatic cancer. Surg Today.
54:1498–1504. 2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Keller U: Nutritional laboratory markers
in malnutrition. J Clin Med. 8(775)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ranasinghe RN, Biswas M and Vincent RP:
Prealbumin: The clinical utility and analytical methodologies. Ann
Clin Biochem. 59:7–14. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Aoyama T, Nakazono M, Segami K, Nagasawa
S, Kano K, Hara K, Maezawa Y, Hashimoto I, Suematsu H, Watanabe H,
et al: Clinical significance of the prealbumin level in gastric
cancer patients who receive curative treatment. J Gastrointest
Cancer. 54:27–34. 2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li JD, Xu XF, Han J, Wu H, Xing H, Li C,
Yu JJ, Zhou YH, Gu WM, Wang H, et al: Preoperative prealbumin level
as an independent predictor of long-term prognosis after liver
resection for hepatocellular carcinoma: A multi-institutional
study. HPB (Oxford). 21:157–166. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kwon CH, Seo HI, Kim DU, Han SY, Kim S,
Lee NK, Hong SB, Ahn JH, Park YM and Noh BG: Clinical significance
of C-reactive protein-to-prealbumin ratio in predicting early
recurrence in resectable pancreatic cancer. Korean J Clin Oncol.
19:11–17. 2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li C, Fan Z, Guo W, Liang F, Mao X, Wu J,
Wang H, Xu J, Wu D, Liu H, et al: Fibrinogen-to-prealbumin ratio: A
new prognostic marker of resectable pancreatic cancer. Front Oncol.
13(1149942)2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Liang Y, Guo H, Man Q, Chang S, Wang E and
Gao S: Prognostic nutritional score based on pretreatment
lymphocyte, platelet, and prealbumin predicts prognosis in patients
with pancreatic cancer. J Surg Oncol. 128:831–843. 2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ishida M, Fujii T, Kishiwada M, Shibuya K,
Satoi S, Ueno M, Nakata K, Takano S, Uchida K, Ohike N, et al:
Japanese classification of pancreatic carcinoma by the Japan
pancreas society: Eighth edition. J Hepatobiliary Pancreat Sci.
31:755–768. 2024.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang Z, Pereira SL, Luo M and Matheson
EM: Evaluation of blood biomarkers associated with risk of
malnutrition in older adults: A systematic review and
meta-analysis. Nutrients. 9(829)2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Park YM, Seo HI, Noh BG, Kim S, Hong SB,
Lee NK, Kim DU and Han SY: Clinical impact of serum prealbumin in
pancreaticobiliary disease. Korean J Clin Oncol. 18:61–65.
2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Jabłońska B, Pawlicki K and Mrowiec S:
Associations between nutritional and immune status and
clinicopathologic factors in patients with pancreatic cancer: A
comprehensive analysis. Cancers (Basel). 13(5041)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cintoni M, Grassi F, Palombaro M,
Rinninella E, Pulcini G, Di Donato A, Salvatore L, Quero G, Tortora
G, Alfieri S, et al: Nutritional interventions during chemotherapy
for pancreatic cancer: A systematic review of prospective studies.
Nutrients. 15(727)2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mękal D, Sobocki J, Badowska-Kozakiewicz
A, Sygit K, Cipora E, Bandurska E, Czerw A and Deptała A:
Evaluation of nutritional status and the impact of nutritional
treatment in patients with pancreatic cancer. Cancers (Basel).
15(3816)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang L, Jin R, Yang X and Ying D: A
population-based study of synchronous distant metastases and
prognosis in patients with PDAC at initial diagnosis. Front Oncol.
13(1087700)2023.PubMed/NCBI View Article : Google Scholar
|
